Recruiting NCT07184203
Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Itraconazole (ITZ).
- Who it may be relevant to
- Registry conditions: Tinea Capitis. Basic parameters: 5 years — 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Egypt
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Comparative Clinicomycologic and Dermoscopic Study Between Daily and Pulse Therapy of Oral Itraconazole in Tinea Capitis in Children
Overview
A study to compare the efficacy of daily therapy versus pulse therapy of oral itraconazole in the treatment of tinea capitis in children based on clinical, mycological and dermoscopic evaluation.
Interventions
- Drug Itraconazole (ITZ)
therapy for tinea capitis orally
Primary outcome measures
- improvement of tinea capitis [Time frame: 3 months]
Eligibility criteria
Inclusion criteria
- Tinea capitis patients with ages ranging from 5 to 18 year
Exclusion criteria
- Patients with contraindications to itraconazole
- Patients with associated scalp disease.
- Patients weighing less than 20 Kg.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Open label
- Primary purpose
- Treatment
Study locations
Egypt · 1 center
- Faculty of Medicine — Alexandria
Identifiers
NCT: NCT07184203 · 0108853